Max Robotics — Global Service Robot Directory + US Certification

About

Daisuke Noro is a urological surgeon and researcher whose work centers on improving outcomes for patients with prostate cancer and refining surgical evaluation techniques. His major contributions lie in two interconnected areas: advancing treatment strategies for high-risk prostate cancer and pioneering the use of cell-free DNA (cfDNA) as a biomarker for surgical trauma. In a notable 2018 study, Noro compared neoadjuvant chemohormonal therapy followed by robot-assisted versus minimum incision endoscopic radical prostatectomy in high-risk patients, providing critical insights into perioperative and oncological outcomes that help guide surgical decision-making. His 2021 investigation into total cfDNA levels as a tool for evaluating surgical damage in urological procedures represents a significant methodological advance, addressing the longstanding challenge of quantifying tissue injury without specific biomarkers. Both papers have garnered 13 citations each, reflecting their growing influence in urological oncology and surgical research. Noro’s work bridges clinical practice and translational science, offering practical biomarkers and comparative effectiveness data that directly impact patient care. His research is particularly valuable for surgeons seeking evidence-based approaches to high-risk prostate cancer management and for investigators exploring non-invasive markers of surgical stress.